×

Why AstraZeneca will be Pfizer's easiest takeover

6:30 PM ET Mon, 5 May 2014

Raghuram Selvaraju, Head of Healthcare Equity Research at Aegis Capital, discusses Pfizer's motivations behind its takeover bid for U.K.-based AstraZeneca.